Ocugen Inc
OCGN
$0.95-0.87%
End of day · as of Oct 13, 2026, 3:30 AM ET
Mkt cap
$416.38M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$1.49M
EPS (H1 2026)
$-0.13
Gross Margin (qtr ended 2026-06-30)
N/A
Profit Margin (qtr ended 2026-06-30)
-1671.84%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Ocugen Inc (OCGN) is a biotechnology company listed on NASDAQ.
Latest reported OCGN revenue for 2026-06-30 was $1.5M. Net income was -$24.9M. Revenue was down 2.9% from 2026-03-31 to 2026-06-30. OCGN currently screens at market cap $416.4M.
Use this OCGN research hub for sector, financials, and filings — not a live tape.
Each line names its own latest cached period. Full OCGN income, balance, and cash tables.
† Total Debt (Q2 2026): Derived: short-term debt plus long-term debt (no total debt stored).
Ocugen Inc (OCGN) is a biotechnology company in the Healthcare sector.
Latest cached Ocugen Inc (OCGN) revenue for Jun 30, 2026 was $1.5M. Net income was -$24.9M. Statements: https://lician.com/financials/ocgn
Ocugen Inc (OCGN) market capitalization is $416.4M on the latest cached snapshot.
Ocugen Inc (OCGN) cached previous close $0.96; day range $0.95 – $0.96; volume 3,266,338. Session quote: https://lician.com/quote/ocgn
Ocugen Inc (OCGN) latest cached earnings event is "OCGN earnings" on Aug 7, 2026. Earnings calendar: https://lician.com/earnings
The latest cached OCGN filing is 8-K · Oct 15, 2026. Filings: https://lician.com/sec/ocgn